Cullinan Therapeutics, Inc. CGEM Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s enterprise value?
- Cullinan Therapeutics, Inc. (CGEM) reported enterprise value of $787.38M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s enterprise value changed year-over-year?
- Cullinan Therapeutics, Inc.'s enterprise value increased by 113.9% year-over-year, from $368.13M to $787.38M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s enterprise value has grown at a -4.3% compound annual growth rate (CAGR), from $627.18M to $525.79M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.